Comparing two knee braces for medial knee osteoarthritis
Official title: ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA
Run by Rush University Medical Center · NCT07224958 · Data updated 2026-11-12
This test compares the ROAM OA brace and the Ossur Unloader One brace to see if they reduce pain and improve walking in people with medial knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | April 27, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT07224958 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40–85 with physician-diagnosed medial compartment knee osteoarthritis, a walking pain score of at least 4 on the VAS, BMI ≤35, able to walk 20 minutes unaided, and willing to wear a brace four or more hours per day.
✕Probably not a fit
Patients with lateral or patellofemoral-predominant OA, prior knee replacement, significant ligament or neurological conditions affecting gait, skin allergy to braces, or inability to tolerate wearing a brace are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center crossover study first compares immediate and short-term biomechanical effects of the Enovis ROAM OA Single Upright Brace and the Ossur Unloader One on knee adduction moment and spatiotemporal gait parameters. Participants wear each brace while undergoing gait analysis, then enter a randomized controlled phase and extended follow-up focused on the ROAM OA brace to track pain and functional outcomes over time. Eligible adults are 40–85 with physician-diagnosed medial compartment OA, moderate walking pain, BMI ≤35, and the ability to walk 20 minutes unaided, and must agree to wear the assigned brace at least four hours per day. Study outcomes combine laboratory gait metrics with patient-reported pain and function measures to describe both biomechanical changes and clinical benefit.
Why it matters
Potential benefit: If successful, the ROAM OA brace could reduce walking pain, improve gait mechanics and daily function, and potentially delay more invasive treatments.
How similar studies have gone: Unloading braces like the Ossur Unloader have shown short-term biomechanical unloading and symptomatic relief in prior studies, but long-term benefits are variable and the ROAM OA brace has limited independent long-term published data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria: * Age 40-85 years. * BMI ≤ 35. * Physician-diagnosed medial compartment knee osteoarthritis. * Visual Analog Scale (VAS) walking pain ≥ 4. * Willing to wear assigned brace ≥ 4 hours/day. * Able to walk independently for 20 minutes unaided. * Stable pain medication regimen ≥ 4 weeks. * ≥3 months since last hyaluronic acid (HA), platelet-rich plasma (PRP), or steroid injection. Exclusion Criteria: * Lateral or patellofemoral osteoarthritis. * Prior knee replacement. * Significant ligament injury or acute lower limb injury. * Neurological condition affecting gait. * Severe psychiatric or neurological disorder affecting pain perception. * Skin condition or allergy preventing brace use. * Current use of another brace or assistive device. * Recent opioid or corticosteroid use (\<4 weeks). * Pregnant. Exclusion Criteria: \-
Where it's running
-
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Markus Wimmer, PhD
- Email: markus_a_wimmer@rush.edu
- Phone: 3129422789
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.